Scienture Holdings, Inc. · NASDAQ:SCNX
Scienture — TRxADE Group — Investor Presentation (May 2021)
20 slides from Scienture's investor presentation, May 19, 2021
Slide 1: Investor Presentation May 2021
t=) ot Experi ience Investor Presentation > NASDAQ: MEDS May 2021
Slide 2: Safe Harbor Statement
Safe Harbor Statement The information set forth herein contains forward-looking statements. Forward-looking statements include all statements that do not relate solely to historical or current facts, including, but not limited to, statements regarding future operations, financial results, cash flows
Slide 3: About TRxADE Group, Inc.
About TRxADE Group, Inc. TRxADE Group, Inc. TRXADE is a technology-enabled health services platform company focused (NASDAQ: MEDS) on digitalizing the retail pharmacy experience by optimizing drug Share Price! $4.08 procurement, the prescription journey and patient engagement in the U.S. MarkenCap!
Slide 4: Divisions of TRXADE Group
Divisions of TRXADE Group Platform Company with Various B2B + B2C Subsidiaries GD OD MEDCHEKS (Health Passport) a (TRADE Marketplace Platform BONUM + HEALTH cn (TeleHealth) INTEGRAF PHARMA SOLUTIONS (Rx Distributor) COMMUNITY SPECIALTY PHARMACY Pharmac’ “Innovation Lab” ( ¥ (Technology Bridge) 1) Pi
Slide 5: TRxADE Marketplace
TRxADE Marketplace Our B2B Pharmaceutical Supply Chain Platform U.S. Pharmaceutical Industry* * Projected $685B per year industry size by 2023 and growing; Over 65,000 pharmacy facilities * Approximately 9 out of 10 Americans live within 5 miles of a community pharmacy * Excluding several large nati
Slide 6: TRxADE Marketplace Solution
TRXADE Marketplace = Our B2B Pharmaceutical Supply Chain Platform Our Marketplace Solution * TRXADE’s exchange platform offers a clear and concise interface that allows registered independent pharmacies to analyze “up-to-the-minute” supply & pricing from multiple pharma suppliers * Economies of scal
Slide 7: Bonum Health
Bonum Health ic BONUM HEALTH Patient Centric Telehealth Services Access to Board-Certified Providers & Health Assessment Tools from Anywhere Individually or through an employer sponsored program, patients can access board-certified medical providers nationwide using the Bonum Health mobile app, webs
Slide 8: Healthcare Infrastructure
Healthcare Infrastructure Pharmacy & Wholesale Divisions Broaden Capabilities INTEGRA| PHARMA SOLUTI S Integra Pharma Solutions Integra Pharma Solutions is the pharmaceutical supplier of choice for healthcare organizations of all sizes. The Company’s expertise in the distribution of products extends
Slide 9: MedCheks Digital Health Passport
MedCheks Digital Health Passport Secure Display of Vaccination & COVID-19 Test Result Status The MedCheks Health Passport, currently in development, will store an_ individual’s health records safely in one place leveraging state-of-the- art encryption & blockchain technology, allowing the holder to
Slide 10: Tomorrow's Digital Health Services Opportunity
Tomorrow’s Digital Health Services Opportunity Current Pharmacy Services Landscape Non-Insurance based technology providers * GoodRx * RO * Hims * Phil New Age Digital Pharmacies * Amazon-PillPak * Alto Pharmacy * Capsule * Nimble * HealthWarehouse ®* True Pill Logistic Providers * ScriptDrop * Uber
Slide 11: TRxADE's Opportunity
TRxADE’s Opportunity The Opportunity Digitally unify brick and mortar retail pharmacies to deliver exceptional patient-centric health services We believe the industry needs: A true partner with experience and A third-party technology solution able to resources! ito, icreate! icamplex ibridges addres
Slide 12: TRxADE's Future Vision: A Digital Health Services Ecosystem
TRxADE’s Future Vision: A Digital Health Services Ecosystem* Goal to Create a Trusted Technology Platform Delivering Exceptional Patient Health Outcomes Telemedicine Telepharmacy Digital Health Passport Access to a _ licensed physician Access to a licensed network pharmacist Comprehensive digital va
Slide 13: TRxADE Industry Comparable Companies
TRxADE Industry Comparable Companies! Valuation? Category: Prescription TRxADE $35M Secondary Marketplace Distribution (B2B) Amerisource (Good Neighbor Pharmacy) $21B Primary Supplier Pharmacy Comps - Retail Distribution McKesson (Healthmart) $288 Primary Supplier Cardinal (Leader) $15B Primary Supp
Slide 14: Selected Financials
Selected Financials * Rapid Growth: 121% TTM growth with strong sequential growth, recent revenue growth bolstered by wholesale transactions Annual Revenue Growth * High Margin: Revenue from transaction fees on marketplace platform (USD $ in Thousands) (Credit Card/PayPal model) does not include the
Slide 15: Management
Management Suren Ajjarapu, Chairman of the Board and Chief Executive Officer Mr. Ajjarapu has served as Chairman of the Board, Chief Executive Officer and Secretary since our acquisition of TRxADE Group, Inc., a Nevada corporation (“TRxADE Nevada”) (our predecessor company) on January 8, 2014, and a
Slide 16: Key Takeaways
Key Takeaways NASDAQ:MEDS TRXADE is a technology-enabled health services platform company focused on digitalizing Annual Revenue Growth the retail pharmacy experience by optimizing drug procurement, the prescription journey (USD $ in Thousands) $17,122 and patient engagement in the U.S. A Tech Focus
Slide 17: Investor Relations Contact
Investor Relations Contact Lucas A. Zimmerman Senior Vice President MZ North America Main: 949-259-4987 MEDS@mzgroup.us www.mzgroup.us Contact Us TRxADE Group, Inc. 3840 Land O' Lakes Boulevard Land O'Lakes, FL 34639 (800) 261-0281 www.trxadegroup.com @TRADE www.trxade.com www.rxintegra.com www.bonu
Slide 18: Appendix: Consolidated Balance Sheet
Appendix: ‘Trxade Group, Inc. Consolidated Balance Sheet celeron bar 3,28 and Oscanber 3,220 tuned bach 3,2001 __pacembor3, 209 pests coat Aas cn + szonne0 sage tun Rc, t ‘oeaso eso rep ets po pe one nie . bere Taleo aaa sane Property ln and Elmers, Nt soe em ot seats pees nies a6 tot et seen om Lnh
Slide 19: Appendix: Consolidated Statements of Operations
Appendix: Consolidated Statements of Operations Consolidated Statements of Operations For the Three Months Ended March 31, 2021 and 2020 (unaudited) 2021 2020 Revenues $ 3,053,235 $ 2,203,320 Cost of Sales 1,669,924 563,184 Gross Profit 1,383,311 1,640,136 Operating Expenses General and Administrati
Slide 20: Appendix: Reconciliation of Net Income to Adj. EBITDA
20 Appendix: Reconciliation of Net Income to Adj. EBITDA Reconciliation of Net Income (Loss) attributable to Trxade Group, Inc., to Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) and Adjusted EBITDA* Net Income (Loss) attributable to Trxade Group, Inc. Add (deduct): Interest